| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/14/2002 | CN1088997C Chinese-medical oral liquid for treating cerebral diseases caused by hypertension and its preparing process |
| 08/14/2002 | CN1088993C Long-acting subcutaneous contraceptive implanting agent containing pregnadienone |
| 08/13/2002 | US6433054 Comprised of polyurethane, polyester, or polyamide elastomer, acrylate polymer, fatty acid or ester, and optionally a drug; made without extruding; nonirritating; good adhesive strength without sticking to skin |
| 08/13/2002 | US6433040 Administering nonaqueous suspension in liquid fluorochemical with plurality of perforated microstructures filled with bioactive agent dispersed therin to nose or lungs; drug delivery |
| 08/13/2002 | US6433027 Medicament compositions based on tiotropium bromide and formoterol fumarate |
| 08/13/2002 | US6433015 Administering a given dosage of creatine |
| 08/13/2002 | US6433006 Method of treatment of seborrheic dermatitis |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action |
| 08/13/2002 | US6432986 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 08/13/2002 | US6432967 Enema and enterically-coated oral dosage forms of azathioprine |
| 08/13/2002 | US6432935 Synergistic mixture of antibiotic, sulfadimidine and fungicide |
| 08/13/2002 | US6432934 Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| 08/13/2002 | US6432928 Complexes and their compositions |
| 08/13/2002 | US6432925 RNA cancer vaccine and methods for its use |
| 08/13/2002 | US6432456 Contains as an effective component a water-soluble component of capsicum annuum l.var.grossumn which is a solanacede plant. |
| 08/13/2002 | US6432451 Polysiloxane stabilization layers on porous particles containing cosmetics or drugs, for topical use |
| 08/13/2002 | US6432450 Effervescent granules with delayed effervescent effect |
| 08/13/2002 | US6432449 Anionic polysaccharides coupled with a metal and a complex leptin protein; biocompatible injections having no side effects |
| 08/13/2002 | US6432448 Time-release coatings containing microcrystalline cellulose, plant extracts, polymers and plasticizers used for drugs and veterinary solid dosage forms, candy, seeds, fertilizers, pesticide tablets, feeds and foods |
| 08/13/2002 | US6432447 Core of fluvastatin, hydroxypropyl methyl cellulose and optionally other excipients, dosage form is color-stable during storage |
| 08/13/2002 | US6432446 Non-arrhythmogenic metabolite of oxybutynin |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/13/2002 | US6432444 Use of bacterial phage associated lysing enzymes for treating dermatological infections |
| 08/13/2002 | US6432442 Gelatin, hydroxypropyl cellulose, water, ibuprofen, acetaminophen, dextromethorphan or pseudoephedrine |
| 08/13/2002 | US6432441 Throat soothing compositions |
| 08/13/2002 | US6432440 Decongestants, contraceptives, lubricants or antiallergens, having low saponification numbers, administered as liquids, so that gelation may occur at physiologically ph and low calcium concentration |
| 08/13/2002 | US6432439 Comprising fluorometholone or clobetasone butyrate, oils, water, phosphatides and cellulose; stable antiinflammatory agents; side effect reduction |
| 08/13/2002 | US6432438 Biodegradable vehicle and filler |
| 08/13/2002 | US6432435 Crosslinked thin films or sheets for use as grafting and wound healing agents; nontoxic and nonantigenic |
| 08/13/2002 | US6432434 Administering lipoic or dihydrolipoic acid as neuroprotectants for nervous system disorders or traumas |
| 08/13/2002 | US6432432 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 08/13/2002 | US6432431 Steroid-containing cataplasms and process for producing the same |
| 08/13/2002 | US6432426 Contains molecular iodine in a concentration above at least 15 ppm and one of triiodide or complexed iodoine may be present; lower concentrations of iodine disinfect without staining skin |
| 08/13/2002 | US6432422 Oil in water emulsion with maxacalcitol; improved skin absorption and heat stability |
| 08/13/2002 | US6432415 Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
| 08/13/2002 | US6432383 Method for administering insulin |
| 08/13/2002 | US6432381 Particulate crystalline drugs with poor water solubility are formulated with a poloxamer and water |
| 08/13/2002 | US6432126 Flexible vascular inducing implants |
| 08/13/2002 | US6431167 Aerosols; controlling lung delivery |
| 08/13/2002 | US6431166 Aerosols; controlling lung delivery |
| 08/13/2002 | CA2271636C Disinfecting microemulsions |
| 08/13/2002 | CA2190624C An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein |
| 08/12/2002 | WO2001034196A2 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2398832A1 Mixture containing rare earths and use thereof |
| 08/08/2002 | WO2002061036A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 08/08/2002 | WO2002060869A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060591A1 Device and method for producing stationary multi-component liquid capillary streams and micrometric and nanometric sized capsules |
| 08/08/2002 | WO2002060532A1 Medicament compositions with negligible side-effects containing betamimetics |
| 08/08/2002 | WO2002060524A2 Enhanced ultrasound detection with temperature dependent contrast agents |
| 08/08/2002 | WO2002060503A1 Resorbable bone cement containing active agents |
| 08/08/2002 | WO2002060501A2 Hydrogel wound dressing,preparation and use thereof |
| 08/08/2002 | WO2002060495A1 Procedure and composition of treatment and/or care of the eye |
| 08/08/2002 | WO2002060487A1 Process for producing aqueous cellulose derivative dispersion |
| 08/08/2002 | WO2002060486A2 Controlled release microsphere system for administration of drug to the eye |
| 08/08/2002 | WO2002060481A1 Methods for treating disease states comprising administration of low levels of antibodies |
| 08/08/2002 | WO2002060474A2 Mixtures of mushroom enzymes and the use thereof for treating maldigestion |
| 08/08/2002 | WO2002060458A2 Compositions and method of tissue superoxygenation |
| 08/08/2002 | WO2002060454A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | WO2002060448A1 Medicinal composition |
| 08/08/2002 | WO2002060446A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 08/08/2002 | WO2002060437A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | WO2002060435A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 08/08/2002 | WO2002060424A2 Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060421A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | WO2002060418A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 08/08/2002 | WO2002060417A1 Binding agent which is stable in storage and used for pharmaceutical applications |
| 08/08/2002 | WO2002060416A1 Polypeptide delivery system and method for their preparation |
| 08/08/2002 | WO2002060415A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 08/08/2002 | WO2002060414A1 Oral osmotic controlled drug delivery system for a sparingly soluble drug |
| 08/08/2002 | WO2002060413A1 Implantable bioartificial active secretion system |
| 08/08/2002 | WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | WO2002060410A2 Methods for sustained release local delivery of drugs for ablation of unwanted tissue |
| 08/08/2002 | WO2002060409A1 Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same |
| 08/08/2002 | WO2002060406A2 Veterinary dermatologic composition |
| 08/08/2002 | WO2002060405A1 Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative |
| 08/08/2002 | WO2002060402A1 Cosmetic products for the reduction of sweat acidity |
| 08/08/2002 | WO2002060391A2 Pharmaceutical composition for the prevention and treatment of scar tissue |
| 08/08/2002 | WO2002060389A2 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 08/08/2002 | WO2002060385A2 Pharmaceutical formulation |
| 08/08/2002 | WO2002060384A2 Pharmaceutical formulation |
| 08/08/2002 | WO2002060379A2 Composition comprising extracts of flos lonicerae, fructus forsythiae and radix scutellariae, uses and preparation thereof |
| 08/08/2002 | WO2002060371A1 Device for inserting a needle-shaped body into living tissue |
| 08/08/2002 | WO2002060350A1 Irradiated stent coating |
| 08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060275A1 Production of capsules and particles for improvement of food products |
| 08/08/2002 | WO2002060272A1 Anticholesterolemic edible oil |
| 08/08/2002 | WO2002046241A3 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| 08/08/2002 | WO2002045699A3 Transdermal therapeutic system comprising the active ingredient oxybutynin |
| 08/08/2002 | WO2002036077A3 Once a day antihistamine and decongestant formulation |
| 08/08/2002 | WO2002030466A3 Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof |
| 08/08/2002 | WO2002030455A3 Agents for the treatment of viral infections |
| 08/08/2002 | WO2002022175A3 Method and composition for treating tumors by selective induction of apoptosis |
| 08/08/2002 | WO2002017894A3 Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 08/08/2002 | WO2002017877A3 Controlled release pharmaceutical pellet compositions for reducing side effects of drugs |